v3.26.1
Goodwill and Intangible Assets (Tables)
9 Months Ended
Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Schedule of Goodwill
The following table sets forth the changes in the carrying amount of goodwill by operating and reportable segment since September 30, 2025 (in thousands).
Sample
Management
Solutions
MultiomicsTotal
Balance - September 30, 2025$505,635 $196,760 $702,395 
Acquisition of UK Biocentre1,207 — 1,207 
Impairment(36,647)(112,436)(149,083)
Currency translation adjustments(7,062)— (7,062)
Balance - June 30, 2026$463,133 $84,324 $547,457 
Accumulated goodwill impairments, June 30, 2026$(36,647)$(112,436)$(149,083)
Schedule of Finite-Lived Intangible Assets
The components of the Company’s identifiable intangible assets as of June 30, 2026 and September 30, 2025 are as follows (in thousands):
June 30, 2026September 30, 2025
CostAccumulated
Amortization
Net Book
Value
CostAccumulated
Amortization
Net Book
Value
Patents$1,220 $1,220 $— $1,220 $1,220 $— 
Completed technology110,872 69,513 41,359 111,501 63,408 48,093 
Trademarks and trade names1,741 410 1,331 727 293 434 
Customer relationships249,378 206,380 42,998 248,846 195,559 53,287 
Total$363,211 $277,523 $85,688 $362,294 $260,480 $101,814 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated future amortization expense for the intangible assets as of June 30, 2026 is as follows for the remainder of fiscal year 2026, the subsequent four fiscal years and thereafter (in thousands):
Remainder of fiscal year 2026$5,650 
202717,988 
202815,107 
202912,474 
203010,893 
Thereafter23,576 
Total$85,688